Loading data for ARMP — first visit, this takes a few seconds.
Armata Pharmaceuticals, Inc. (ARMP)
NYSE American: ARMP
· 即時價格 · USD
5.58
+0.30 (5.68%)
收盤價： Sep 02, 2026, 7:28 PM
股價、關鍵數字和最新消息，都在這一頁。
Armata Pharmaceuticals, Inc.（ARMP）股價、分析與資料
無可用資料
| 買價 | 5.55 |
| 市值 | 207M |
| 營收 (ttm) | 5.54M |
| 淨利（ttm） | -192M |
| 1.33 | |
| -5.29 | |
| n/a | |
| -3.55 | |
| P/B (ttm) | -0.90 |
| P/S (ttm) | 37.43 |
| 財報日期 | Nov 11, 2026 |
| 賣價 | 5.6 |
| 成交量 | 49,115 |
| 20 日平均成交量 | 151,901 |
| 開盤價 | 5.36 |
| 前收盤價 | 5.28 |
| 當日區間 | 5.27 - 5.61 |
| 52 週範圍 | 2.54 - 16.34 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 ARMP
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Ange...
完整的公司簡介財報驚奇
Armata Pharmaceuticals 已於 Aug 12, 2026 公布季度財報：
- 營收為 $0 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 1.2 超出預期 1.64, 年增 513.79% 成長.
第 1 頁，共 2 頁